Oruka Therapeutics, Inc. ORKA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s operating lease ROU assets?
- Oruka Therapeutics, Inc. (ORKA) reported operating lease ROU assets of $1.69M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Oruka Therapeutics, Inc.'s operating lease ROU assets increased by 107.2% year-over-year, from $814K to $1.69M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s operating lease ROU assets has grown at a 33.7% compound annual growth rate (CAGR), from $428K to $1.83M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.